Ravidasvir
id:
ravidasvir-299-5813928
title:
Ravidasvir
text:
Ravidasvir (PPI-668) is an investigational NS5A inhibitor in clinical trials for chronic hepatitis C genotype 4. It is on the World Health Organization's List of Essential Medicines. Preliminary clinical trial results were announced in Nov 2015. In April 2017, press reports stated that a combination treatment involving ravidasvir and sofosbuvir had achieved a 97% clearup rate against hepatitis C in a clinical trial conducted in Malaysia and Thailand, and 100% in another conducted in Egypt. It ha
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Ravidasvir
date created:
date modified:
2023-12-28T05:54:55Z
main entity:
{"identifier":"Q25101668","url":"https://www.wikidata.org/entity/Q25101668"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3d/Ravidasvir.svg","width":512,"height":284}
fields total:
13
integrity:
15